EXBLIFEP

This brand name is authorized in United States. It is also authorized in Lithuania.

Active ingredients

The drug EXBLIFEP contains a combination of these active pharmaceutical ingredients (APIs):

1	Cefepime UNII 807PW4VQE3 - CEFEPIME
	Cefepime is a broad-spectrum, bactericidal antibiotic, with activity against a wide range of Gram-positive and Gram-negative bacteria, including many strains resistant to aminoglycosides or third generation cephalosporins. It has a reduced affinity for beta-lactamases.
	Read more about Cefepime
2	Enmetazobactam UNII 80VUN7L00C - ENMETAZOBACTAM

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
EXBLIFEP Solution for injection	MPI, US: SPL/PLR	FDA, National Drug Code (US)
EXBLIFEP Powder for concentrate for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DE51		J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DE Fourth-generation cephalosporins
Discover more medicines within J01DE51

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
LT	Valstybinė vaistų kontrolės tarnyba	1099361
US	FDA, National Drug Code	83289-101